Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,354,998 papers from all fields of science
Search
Sign In
Create Free Account
HE3286
Known as:
HE-3286
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Effects of Synthetic Anti-Inflammatory Sterol in CB3V-Induced Myocarditis: A Morphological Study on Heart Muscle Tissue
P. Castrogiovanni
,
F. Trovato
,
+9 authors
S. Castorina
2016
Corpus ID: 15248628
Cell-mediated immune events play a role in the pathogenesis of myocarditis provoked by Group B coxsackievirus (CVB). Studies…
Expand
2014
2014
Combined inhibition of angiotensin II type 1 receptor and ASK1 significantly attenuates autoimmune optic neuritis
Xiaoli Guo
,
K. Namekata
,
C. Harada
,
T. Harada
2014
Corpus ID: 17085229
Program Number: 5769 Poster Board Number: B0105 Presentation Time: 8:30 AM–10:15 AM Combined inhibition of angiotensin II type 1…
Expand
2013
2013
A synthetic anti‐inflammatory sterol improves insulin sensitivity in insulin‐resistant obese impaired glucose tolerance subjects
C. Reading
,
D. Stickney
,
+4 authors
J. Frincke
Obesity
2013
Corpus ID: 1913530
To study the activity of HE3286 (17α‐ethynylandrost‐5‐ene‐3β,7β,17β‐triol), an anti‐inflammatory sterol that is active in models…
Expand
2011
2011
Studies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.
C. Ahlem
,
Michael R. Kennedy
,
+6 authors
J. Frincke
International Journal of Clinical and…
2011
Corpus ID: 24055720
17α-Ethynyl-androst-5ene-3β, 7β, 17β-triol (HE3286) is an orally bioavailable analogue of androst-5-ene-3β,7β,17β-triol, a non…
Expand
2010
2010
A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats.
Min Lu
,
D. Patsouris
,
+5 authors
J. Olefsky
American Journal of Physiology. Endocrinology and…
2010
Corpus ID: 281161
Tissue macrophage inflammatory pathways contribute to obesity-associated insulin resistance. Here, we have examined the efficacy…
Expand
2010
2010
Oral treatment with HE3286 ameliorates disease in rodent models of rheumatoid arthritis.
D. Auci
,
K. Mangano
,
+6 authors
F. Nicoletti
International Journal of Molecular Medicine
2010
Corpus ID: 18439087
HE3286 (17alpha-ethynyl-5-androstene-3beta, 7beta, 17beta-triol) is an orally bio-available synthetic derivative of naturally…
Expand
2010
2010
HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression
D. Conrad
,
Angela Wang
,
+8 authors
D. Auci
Journal of Inflammation
2010
Corpus ID: 4495745
Background17α-Ethynyl-5-androsten-3β, 7β, 17β-triol (HE3286) is a synthetic derivative of an endogenous steroid androstenetriol…
Expand
2009
2009
HE3286: A Novel Synthetic Steroid as an Oral Treatment for Autoimmune Disease
C. Ahlem
,
D. Auci
,
+4 authors
F. Nicoletti
Annals of the New York Academy of Sciences
2009
Corpus ID: 8938231
HE3286 (17α‐ethynyl‐5‐androstene‐3β, 7β, 17β‐triol) is a synthetic derivative of a natural anti‐inflammatory steroid, β‐AET (5…
Expand
2009
2009
An Orally Bioavailable Synthetic Analog of an Active Dehydroepiandrosterone Metabolite Reduces Established Disease in Rodent Models of Rheumatoid Arthritis
H. Offner
,
G. Firestein
,
+6 authors
D. Auci
Journal of Pharmacology and Experimental…
2009
Corpus ID: 12627535
Dehydroepiandrosterone (DHEA) treatment provides diverse anti-inflammatory benefits in rodent models of diseases, including…
Expand
2007
2007
A New Orally Bioavailable Synthetic Androstene Inhibits Collagen‐Induced Arthritis in the Mouse
D. Auci
,
Laurie J. Kaler
,
+4 authors
H. Offner
Annals of the New York Academy of Sciences
2007
Corpus ID: 32258529
Abstract: Dehydroepiandrosterone (DHEA) has attracted much interest because of its many antiaging, metabolic and immune…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE